• Health Care

Eisai: Initiation of New Phase III Clinical Study (Ahead 3-45) of ban2401 Preclinical (Asymptomatic) Alzheimer’s Disease

New Delhi, July 14, 2020: The Alzheimer's Clinical Trials Consortium (ACTC), Eisai Co., Ltd., and Biogen Inc. announced today that…

Bengaluru hosts a first of its kind symposium on Next Generation Antibody Platforms Co-hosted by Syngene International, Thermo Fisher and Amgen

Bengaluru, December 06, 2018: Syngene International, a global Contract Research Organization in association with industry leaders, Thermo Fisher Scientific and Amgen…